TickerFacts.

A business in context

ORKA research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-10-20 · 0000907654-26-000110

  2. 4 · Ownership change

    Report date 2026-10-15 · 0000907654-26-000108

  3. 4 · Ownership change

    Report date 2026-10-12 · 0000907654-26-000106

  4. 4 · Ownership change

    Report date 2026-10-01 · 0000907654-26-000104

  5. 4 · Ownership change

    Report date 2026-09-21 · 0000907654-26-000102

  6. 4 · Ownership change

    Report date 2026-09-21 · 0000907654-26-000100

  7. 4 · Ownership change

    Report date 2026-09-15 · 0000907654-26-000098

  8. 4 · Ownership change

    Report date 2026-09-11 · 0000907654-26-000097

  9. 8-K · Current report

    Report date 2026-08-24 · 0001213900-26-093021 · Items 5.02,9.01

  10. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001213900-26-087231

  11. 8-K · Current report

    Report date 2026-08-10 · 0001213900-26-086933 · Items 2.02,9.01

  12. 8-K · Current report

    Report date 2026-06-02 · 0001213900-26-065294 · Items 5.07

  13. 8-K · Current report

    Report date 2026-05-29 · 0001213900-26-063481 · Items 8.01,9.01

  14. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001213900-26-055769

  15. 8-K · Current report

    Report date 2026-04-27 · 0001213900-26-050249 · Items 2.02,8.01,9.01

  16. 8-K · Current report

    Report date 2026-04-27 · 0001213900-26-047743 · Items 7.01,8.01,9.01

  17. DEF 14A · Proxy statement

    Report date 2026-06-02 · 0001213900-26-045159

  18. 10-K · Annual report

    Report date 2025-12-31 · 0001213900-26-026929

  19. 8-K · Current report

    Report date 2025-12-11 · 0001213900-25-120676 · Items 5.02,9.01

  20. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001213900-25-109182

  21. 8-K · Current report

    Report date 2025-09-17 · 0001213900-25-090129 · Items 1.01,3.02,7.01,9.01

  22. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001213900-25-074281

  23. 8-K · Current report

    Report date 2025-07-01 · 0001213900-25-060352 · Items 5.02,9.01

  24. 8-K · Current report

    Report date 2025-06-02 · 0001213900-25-050756 · Items 5.07

  25. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001213900-25-043279

  26. DEF 14A · Proxy statement

    Report date 2025-06-02 · 0001213900-25-033316

  27. 10-K · Annual report

    Report date 2024-12-31 · 0001213900-25-021165

  28. 8-K · Current report

    Report date 2025-02-04 · 0001213900-25-010525 · Items 1.01

  29. 8-K · Current report

    Report date 2024-12-17 · 0001213900-24-110303 · Items 1.01

  30. SC 13D/A · Ownership disclosure

    0001213900-24-101117

  31. 8-K · Current report

    Report date 2024-11-14 · 0001213900-24-099645 · Items 5.07

  32. SC 13G/A · Ownership disclosure

    0001274173-24-000089

  33. 8-K · Current report

    Report date 2024-11-14 · 0001213900-24-098530 · Items 8.01,9.01

  34. SC 13G/A · Ownership disclosure

    0001104659-24-119331

  35. SC 13G/A · Ownership disclosure

    0001013594-24-000956

  36. SC 13G/A · Ownership disclosure

    0000919574-24-006793

  37. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001213900-24-097443

  38. SC 13D/A · Ownership disclosure

    0000902664-24-005943

  39. DEF 14A · Proxy statement

    Report date 2024-11-14 · 0001140361-24-043698

  40. SC 13G · Ownership disclosure

    0000315066-24-002024

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 50 transaction rows50SGrant / award: 2 transaction rows2AExercise / conversion: 36 transaction rows36MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

90 matching transaction rows. Showing 51 to 90.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-08-14
2026-08-14
Quinlan Paul T
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock14696.0107.97
2026-08-14
2026-08-14
Quinlan Paul T
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock10434.0107.14
2026-08-14
2026-08-14
Quinlan Paul T
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock3630.0106.05
2026-08-14
2026-08-14
Quinlan Paul T
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock42000.012.5
2026-08-14
2026-08-14
Quinlan Paul T
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock10000.07.8
2026-08-14
2026-08-14
Quinlan Paul T
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Employee Warrant (right to buy)
Derivative security
10000.00.0
2026-08-14
2026-08-14
Quinlan Paul T
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Employee Stock Option (right to buy)
Derivative security
42000.00.0
2026-08-13
2026-08-14
Agarwal Arjun
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock2100.0104.67
2026-08-13
2026-08-14
Agarwal Arjun
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock8542.012.5
2026-08-13
2026-08-14
Agarwal Arjun
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock1458.034.39
2026-08-13
2026-08-14
Agarwal Arjun
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock2358.0108.46
2026-08-13
2026-08-14
Agarwal Arjun
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock2142.0107.71
2026-08-13
2026-08-14
Agarwal Arjun
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock2132.0105.57
2026-08-13
2026-08-14
Agarwal Arjun
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1268.0106.63
2026-08-13
2026-08-14
Agarwal Arjun
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Employee Stock Option (right to buy)
Derivative security
8542.00.0
2026-08-13
2026-08-14
Agarwal Arjun
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Employee Stock Option (right to buy)
Derivative security
1458.00.0
2026-07-15
2026-07-15
Goncalves Joana
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock300.087.25
2026-07-15
2026-07-15
Goncalves Joana
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock3500.06.84
2026-07-15
2026-07-15
Goncalves Joana
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock3500.07.8
2026-07-15
2026-07-15
Goncalves Joana
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock400.084.37
2026-07-15
2026-07-15
Goncalves Joana
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock2497.085.86
2026-07-15
2026-07-15
Goncalves Joana
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock3803.086.68
2026-07-15
2026-07-15
Goncalves Joana
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Employee Warrant (right to buy)
Derivative security
3500.00.0
2026-07-15
2026-07-15
Goncalves Joana
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Employee Stock Option (right to buy)
Derivative security
3500.00.0
2026-07-13
2026-07-13
Agarwal Arjun
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock8541.012.5
2026-07-13
2026-07-13
Agarwal Arjun
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock1458.034.39
2026-07-13
2026-07-13
Agarwal Arjun
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock300.085.63
2026-07-13
2026-07-13
Agarwal Arjun
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock3743.084.26
2026-07-13
2026-07-13
Agarwal Arjun
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock5656.084.9
2026-07-13
2026-07-13
Agarwal Arjun
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock300.083.07
2026-07-13
2026-07-13
Agarwal Arjun
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Employee Stock Option (right to buy)
Derivative security
1458.00.0
2026-07-13
2026-07-13
Agarwal Arjun
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Employee Stock Option (right to buy)
Derivative security
8541.00.0
2026-07-01
2026-07-01
Fairmount Funds Management LLC; Fairmount Healthcare Co-Invest III L.P.; Fairmount Healthcare Fund II L.P.; Harwin Peter Evan; Kiselak TomasS · Sale
Disposed
Common Stock3553410.084.43
2026-07-01
2026-07-01
Fairmount Funds Management LLC; Fairmount Healthcare Co-Invest III L.P.; Fairmount Healthcare Fund II L.P.; Harwin Peter Evan; Kiselak TomasC · Conversion
Acquired
Common Stock3553410.0n/a
2026-07-01
2026-07-01
Fairmount Funds Management LLC; Fairmount Healthcare Co-Invest III L.P.; Fairmount Healthcare Fund II L.P.; Harwin Peter Evan; Kiselak TomasC · Conversion
Disposed
Series B Preferred Stock
Derivative security
42641.00.0
2026-07-01
2026-07-01
Sandler Laura Lee
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock5000.07.8
2026-07-01
2026-07-01
Sandler Laura Lee
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock500.095.47
2026-07-01
2026-07-01
Sandler Laura Lee
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock2263.094.75
2026-07-01
2026-07-01
Sandler Laura Lee
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock2237.093.85
2026-07-01
2026-07-01
Sandler Laura Lee
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Employee Warrant (right to buy)
Derivative security
5000.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0000907654Oruka Therapeutics, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names
  • ARCA biopharma, Inc. · former SEC name · 2009-01-28 to 2024-08-30
  • NUVELO INC · former SEC name · 2003-02-04 to 2009-01-27
  • HYSEQ INC · former SEC name · 1997-07-17 to 2003-01-28

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2023-12-31$0$0
2022-12-31$0$0
2021-12-31$0$0
2020-12-31$0$0
2019-12-31$0$0
2018-12-31$0$0
2017-12-31$0$0

Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

Explore the CPI history ↗